TABLE 2.
Treatment | Minimal inhibitory titer |
MIC (μg/ml) |
||||
---|---|---|---|---|---|---|
24 h | 72 h | 120 h | 24 h | 72 h | 120 h | |
Mock | >1/2 | >1/2 | >1/2 | |||
Gentamicin (10 μg/ml) | >1/2 | 1/2 | 1/4 | |||
Gentamicin (10 μg/ml) + AR-12 (1 μM) | >1/2 | 1/2 | 1/4 | |||
Amikacin (20 μg/ml) | >1/2 | 1/2 | 1/8 | |||
Amikacin (20 μg/ml) + AR-12 (1 μM) | >1/2 | 1/2 | 1/8 | |||
Kanamycin (40 μg/ml) | >1/2 | >1/2 | 1/4 | |||
Kanamycin (40 μg/ml) + AR-12 (1 μM) | >1/2 | >1/2 | 1/4 | |||
Streptomycin (80 μg/ml) | >1/2 | >1/2 | 1/2 | |||
Streptomycin (80 μg/ml) + AR-12 (1 μM) | >1/2 | >1/2 | 1/2 | |||
Mock lysate + gentamicin | 2 | 2 | 2 | |||
Mock lysate + amikacin | 2 | 2 | 2 | |||
Mock lysate + kanamycin | 4 | 4 | 4 | |||
Mock lysate + streptomycin | 16 | 16 | 16 | |||
MH broth + gentamicin | 2 | 2 | 2 | |||
MH broth + amikacin | 2 | 2 | 2 | |||
MH broth + kanamycin | 4 | 4 | 4 | |||
MH broth + streptomycin | 16 | 16 | 16 |